Search
for
Sort by
Research 31–60 of 1000+
- Comparative efficacy and safety of systemic steroids, oral JAK inhibitors and Contact Immunotherapy in the Treatment of severe alopecia areata: a systematic review and network meta-analysis
- Relapse of alopecia areata during ongoing Janus kinase inhibitor therapy is not uncommon and usually occurs in previously affected areas: A multicenter Italian real-world study
- Adverse Hair Reactions to New Targeted Therapies for Cancer
- Roles of tumor suppressors in regulating tumor-associated inflammation
- EGFR inhibitor-induced folliculitis decalvans: a case series and management guidelines
- Tofacitinib for the treatment of severe alopecia areata and variants: A study of 90 patients
- Species Differences in Prostatic Steroid 5<i>α</i>-Reductases of Rat, Dog, and Human
- Reversal of Alopecia Areata Following Treatment With the JAK1/2 Inhibitor Baricitinib
- Sex steroid synthesis in human skin in situ: The roles of aromatase and steroidogenic acute regulatory protein in the homeostasis of human skin
- SYK inhibitor entospletinib prevents ocular and skin GVHD in mice
- Targeting host cell proteases as a potential treatment strategy to limit the spread of SARS‐CoV‐2 in the respiratory tract
- Frontal fibrosing alopecia: efficacy of treatment modalities
- The concealed side of caspases: beyond a killer of cells
- Relative Efficacy of Minoxidil and the 5-α Reductase Inhibitors in Androgenetic Alopecia Treatment of Male Patients
- Response to tofacitinib therapy of eyebrows and eyelashes in alopecia areata
- Protein kinase C is a key target for attenuation of Leigh syndrome by rapamycin
- Integrated single-cell chromatin and transcriptomic analyses of peripheral immune cells in patients with alopecia areata
- Abstracts
- Post-marketing safety signals of four JAK inhibitors for alopecia areata: an indication-restricted FAERS pharmacovigilance study
- Cepharanthine inhibits enterovirus entry by endolysosomal deacidification and exhibits protective activity <i>in vivo</i>
- A Bibliometric Analysis of Alopecia Areata Literature over the Past 50 Years.
- Skin
- Patient preferences for treatment characteristics of Janus kinase inhibitors for alopecia areata: a discrete choice experiment
- TYK2 Inhibition with Deucravacitinib Improves Clinical Outcomes and Resolves Interferon-Driven Inflammation in Lichen Planopilaris
- Hyperinnervation inhibits organ-level regeneration in mammalian skin
- Ca <sup>2+</sup> -mediated protein citrullination regulates proliferation in the regenerating and malignant CNS
- JAK-centric explainable few-shot gene-expression diagnosis framework for alopecia via MultiPLIER priors and relation-style set-to-set comparison
- Systemic Inflammation Marker Alterations in Severe Alopecia Areata Patients Treated with Janus Kinase Inhibitors
- Effectiveness of baricitinib in severe alopecia areata in real life: a retrospective study of 87 patients
- Impacto del desequilibrio del microbioma del cuero cabelludo en la severidad de la alopecia areata, marcadores inflamatorios y cambios post-tratamiento